ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

Novartis offers payment plan for high-cost heart medicine
Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden access by offering zero-interest EMI options. This strategy addresses the drug's high cost, previously ₹1.2 lakh pe
Announcement as on 27 May 2025

Market volatility derails Novartis' plan to sell stake in its India arm
Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strategic reviews and potential interest, fluctuations in stock prices and declining sales present hurdles in reaching a de
Announcement as on 01 April 2025

PTC Inks License And Collaboration Deal With Novartis For PTC518 Huntington's Disease Program
(RTTNews) - Biopharmaceutical company PTC Therapeutics, Inc. (PTCT) announced Monday the signing of an exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corp., a subsidiary of Novartis AG (NVS), for its PTC518 Huntington's
Announcement as on 02 December 2024

Novartis hikes sales and profit guidance for the year

Announcement as on 29 October 2024

Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Novartis NVS announced results from the six-month, double-blind trial period of the late-stage APPEAR-C3G study of Fabhalta.
Announcement as on 27 May 2024

Announcements by Novartis first page | Next page | Prev page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 782.34
  • 12Day Average: 783.66
  • 20Day Average: 788.66
  • 50Day Average: 820.57
  • 100Day Average: 865.68
  • 150Day Average: 919.4
  • 200Day Average: 892.64

500672 Indicators & signals

Indicator MACD (12,26,9)

785.02, 796.43, -12.91
Indicator MACD is in negative zone

Indicator ADX (14)

34.14, 9.26, 18.86
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Tue Dec 2025 780.30 773.00 to 785.20 0.59% 0.73 times
29 Mon Dec 2025 775.70 775.00 to 791.60 -1.26% 0.58 times
26 Fri Dec 2025 785.60 775.00 to 792.40 -0.21% 0.84 times
24 Wed Dec 2025 787.25 780.30 to 789.90 0.56% 0.6 times
23 Tue Dec 2025 782.85 780.00 to 794.95 0.1% 0.52 times
22 Mon Dec 2025 782.05 772.35 to 798.95 -0.87% 1.62 times
19 Fri Dec 2025 788.90 777.00 to 789.00 0.71% 0.75 times
18 Thu Dec 2025 783.30 779.05 to 786.00 1.1% 0.78 times
17 Wed Dec 2025 774.75 773.35 to 783.00 0.35% 0.33 times
16 Tue Dec 2025 772.05 766.25 to 799.85 -2.35% 2.43 times
15 Mon Dec 2025 790.65 788.05 to 808.95 -1.24% 1.55 times
12 Fri Dec 2025 800.55 795.00 to 812.45 0.01% 4.11 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top